J & amp;J Talks Up Surgical Robotics Plans

Few medtech sectors are as hot as surgical robotics is right now, so it comes as no surprise that analysts tried to dig for information about Johnson &Johnson's plans for the market during the company's third-quarter earnings call Tuesday. "I couldn't be more bullish around how J&J is going to create value in this space," Ashley McEvoy, EVP and worldwide chairman of Johnson &Johnson's medical device segment, said during the call in response to an analyst's question about surgical robotics. "The goal that we're trying to achieve is really to make medical interventions smarter, less invasive, more personalized, quite frankly, to change the standard of care, not just for the next 10 years, but to 20 years and 30 years." The New Brunswick, NJ-based company strengthened its surgical robotics offerings earlier this year with its $3.4 billion acquisition of Auris Health. Through that acquisition, J&J added the Monarch platform to its offering, an FDA-cleared robotic system currently used in bronchoscopic procedures. McEvoy said Monarch is off to a great start and the system has been used to conduct more than 1,000 bronchoscopes.  "We have a very healthy pipeline with Monarch for not just lung biopsies, but potentially lung treatment via ablation, and potential treatment via oncolytic viruses so that program is well on its way," she said, adding that future applications of Monarch could include endo...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news

Related Links:

Publication date: Available online 31 July 2020Source: European UrologyAuthor(s): Ryan L. Steinberg, Brett A. Johnson, Jodi Antonelli, Margaret S. Pearle
Source: European Urology - Category: Urology & Nephrology Source Type: research
ConclusionsPatients prescribed new opiates for acute nephrolithiasis and those with an existing opioid prescription are likely to require refills before resolution of the stone episode. Larger stones that require surgery (not spontaneous passage) also increase the risk. Timely treatment of these patients and initial treatment with non-narcotics may reduce the risk of prolonged opiate use.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
AbstractOsteoporosis and nephrolithiasis are common multifactorial disorders with high incidence and prevalence in the adult population worldwide. Both are associated with high morbidity and mortality if not correctly diagnosed and accurately treated. Nephrolithiasis is considered a risk factor for reduced bone mineral density. Aim of this retrospective longitudinal study was to evaluate if osteoporosis is a predictive factor for the nephrolithiasis occurrence. Free-living subjects referring to “COMEGEN” general practitioners cooperative operating in Naples, Southern Italy. Twelve thousand seven hundred ninety-...
Source: Calcified Tissue International - Category: Orthopaedics Source Type: research
This study was conducted to evaluate preoperative risk factors for development of complications of percutaneous nephrolithotomy (PCNL). All consecutive patients aged  ≥ 16 years who underwent PCNL during 2015 were retrospectively reviewed. Non-contrast CT (NCCT) was performed for all patients to evaluate stone complexity. The technique of PCNL was the same for all patients. Intra-operative and postoperative complications were recorded and classified based on modified Clavien system. The differences in preoperative data (patients, renal and stone characteristics including Guy’s and STONE scores) ...
Source: Urolithiasis - Category: Urology & Nephrology Source Type: research
AbstractObjectiveTo study the etiological profile and patterns of clinical presentations of urolithiasis (UL) in children.MethodsThis observational study included patients
Source: Indian Journal of Pediatrics - Category: Pediatrics Source Type: research
A machine-learning algorithm can use clinical data from a patient's electronic health record to arrive at a quality-of-life score, which can help determine whether or not to perform surgery.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Urology News Source Type: news
Rationale: Mutations in the hepatocyte nuclear factor-1-beta (HNF1B) gene result in a very variable presentation, including maturity onset diabetes of the young (MODY), renal cysts, renal dysplasia, and autosomal dominant tubulointerstitial kidney disease (ADTKD), which is characterized by tubular damage, renal fibrosis, and progressive renal dysfunction. Patient concerns: A 22-year-old man came to the hospital presenting with hyperglycemia, hyperuricemia and elevated serum creatinine. His urine protein was within the normal range. The ultrasound examination revealed shrunken kidneys with renal cysts. The patient's mo...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
Parents and caretakers are increasingly feeding infants and young children plant-based “milk” (PBM) alternatives to cow milk (CM). The US Food and Drug Administration currently defines “milk” and related milk products by the product source and the inherent nutrients provided by bovine milk. Substitution of a milk that does not provide a similar nutritional profile to CM can be deleterious to a child's nutritional status, growth, and development. Milk's contribution to the protein intake of young children is especially important. For almond or rice milk, an 8 oz serving provides only about 2% or 8%, ...
Source: Journal of Pediatric Gastroenterology and Nutrition - Category: Gastroenterology Tags: Society Paper Source Type: research
Interview with Calyani Ganesan, MD, Alan Pao, and Calyani Ganesan, MD, authors of Analysis of Primary Hyperparathyroidism Screening Among US Veterans With Kidney Stones
Source: JAMA Specialty Journals Author Interviews - Category: General Medicine Authors: Source Type: podcasts
Conditions:   Urolithiasis;   Urinary Tract Stones;   Renal Colic;   Deep Learning Reconstruction Intervention:   Diagnostic Test: Abdominopelvic low dose CT Sponsor:   Centre Hospitalier Universitaire, Amiens Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bronchoscopy | China Health | Endoscopy | Gastroenterology | Kidney Stones | Marketing | Medical Devices | Medical Ethics | Mergers and Aquisitions | Orthopaedics | Surgery | Urology & Nephrology | USA Health